Comments

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELGrNYSE
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.038200
0.008227.33%
At Close: -
$0.040000
0.00184.71%
After Hours: Aug 5, 7:22 PM EDT
15 minutes delayed
Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELGr) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGr) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELGr)?

A

There have been no specific sales or earnings guidance reported for Bristol-Myers Squibb Company Celegne Contingent Value Rights in recent months.

Browse guidance and forecast on all stocks.